{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:04:25Z","timestamp":1788372265297,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015739","name":"Bayer Vital GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.oret.2025.09.004","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:09:53Z","timestamp":1758078593000},"page":"241-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adherence to Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"10","author":[{"given":"Frank G.","family":"Holz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3873-0581","authenticated-orcid":false,"given":"Focke","family":"Ziemssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Bauer-Steinhusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Wachtlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Sch\u00fcrks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1755-7396","authenticated-orcid":false,"given":"Katrin","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6844-4243","authenticated-orcid":false,"given":"Tobias","family":"Machewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Lanzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9640-4103","authenticated-orcid":false,"given":"Albrecht","family":"Lommatzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.09.004_bib1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oret.2025.09.004_bib2","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oret.2025.09.004_bib3","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.004_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bjophthalmol-2014-305327","article-title":"Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration","volume":"99","author":"Holz","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.004_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40123-023-00867-x","article-title":"XTEND: two-year results from a global observational study investigating proactive dosing of intravitreal aflibercept in neovascular age-related macular degeneration","volume":"13","author":"Korobelnik","year":"2024","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.oret.2025.09.004_bib6","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s00417-021-05073-8","article-title":"PERSEUS 24-month analysis: a prospective non-interventional study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Germany in patients with neovascular age-related macular degeneration","volume":"259","author":"Eter","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.004_bib7","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/ceo.13949","article-title":"Neovascular age-related macular degeneration: a review of findings from the real-world fight retinal blindness! Registry","volume":"49","author":"Nguyen","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.004_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00347-019-01005-4","volume":"117","author":"Holz","year":"2020","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.oret.2025.09.004_bib9","first-page":"311","article-title":"Prospective evaluation of visual acuity assessment: a comparison of Snellen versus ETDRS charts in clinical practice (an AOS thesis)","volume":"107","author":"Kaiser","year":"2009","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.oret.2025.09.004_bib10","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"10.1016\/j.oret.2025.09.004_bib11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2147\/OPTH.S45248","article-title":"Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice","volume":"7","author":"Yuzawa","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.004_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41687-018-0031-z","article-title":"Design and development of the MacTSQ measure of satisfaction with treatment for macular conditions used within the IVAN trial","volume":"2","author":"Mitchell","year":"2017","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.oret.2025.09.004_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ophtha.2020.07.060","article-title":"Nonadherence or nonpersistence to intravitreal injection therapy for neovascular age-related macular degeneration: a mixed-methods systematic review","volume":"128","author":"Okada","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.004_bib14","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00417-020-04798-2","article-title":"Systematic review: non-adherence and non-persistence in intravitreal treatment","volume":"258","author":"Ehlken","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.004_bib15","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/IAE.0000000000001681","article-title":"Treatment of neovascular age-related macular degeneration patients with vascular endothelial growth factor inhibitors in everyday practice: identification of Health Care Constraints in Germany-The PONS Study","volume":"38","author":"Ehlken","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.09.004_bib16","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.2147\/OPTH.S325763","article-title":"Importance of treatment duration: unmasking barriers and discovering the reasons for undertreatment of anti-VEGF agents in neovascular age-related macular degeneration","volume":"15","author":"Sobolewska","year":"2021","journal-title":"Clin Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025004130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025004130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:00:05Z","timestamp":1773925205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025004130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2468653025004130"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.09.004","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}